#clinicaltrials

Blockchain technology is no longer just associated with cryptocurrencies like Bitcoin. In recent years, it has emerged as a game-changing technology with a wide range of applications across various industries. One of the most significant applications of blockchain technology is in healthcare and real estate. In this blog post, we will explore how blockchain is being used in these industries and more.

Healthcare

The healthcare industry is one of the most data-intensive industries. Medical records, patient information, and clinical trials are just a few examples of the vast amount of data that healthcare providers need to manage. Blockchain technology can help healthcare providers manage this data more efficiently and securely.

One of the most significant benefits of blockchain technology in healthcare is the ability to store data securely and transparently. Blockchain technology allows healthcare providers to store patient data in a decentralized network, which means that the data cannot be altered or deleted. This ensures that patient data is secure and protected from cyber attacks.

Another use case of blockchain technology in healthcare is the management of clinical trials. Clinical trials are an essential part of the drug development process, but they are often plagued by inefficiencies and fraud. Blockchain technology can help streamline the clinical trial process by providing a secure and transparent platform for managing trial data.

Real Estate

Real estate is another industry that is ripe for disruption by blockchain technology. One of the most significant challenges in real estate is the lack of transparency and trust between buyers, sellers, and intermediaries. Blockchain technology can help address these challenges by providing a secure and transparent platform for real estate transactions.

One of the most significant benefits of blockchain technology in real estate is the ability to streamline the buying and selling process. Blockchain technology can help automate many of the processes involved in real estate transactions, such as property title transfers, mortgage applications, and property inspections.

Another use case of blockchain technology in real estate is the creation of tokenized assets. Tokenized assets are digital representations of physical assets, such as real estate properties. Tokenization allows investors to buy and sell fractional ownership of these assets, which can help make real estate investing more accessible to a broader range of investors.

Other Use Cases

Blockchain technology has the potential to transform many other industries beyond healthcare and real estate. Here are a few other use cases of blockchain technology:

Supply Chain Management: Blockchain technology can help improve supply chain management by providing a secure and transparent platform for tracking goods and products from manufacturing to delivery.

Identity Management: Blockchain technology can help improve identity management by providing a secure and decentralized platform for storing and managing identity information.

Voting Systems: Blockchain technology can help improve voting systems by providing a secure and transparent platform for recording and counting votes.

Conclusion

Hookworm Vaccine Study: Phase 2 Study to Assess the Safety, Efficacy and Immunogenicity of Na-GST-1/Alhydrogel® Co-administered with Different Toll-Like Receptor Agonists in Hookworm-Naïve Adults.

Diverse enrollment and efficient clinical trial recruitment can work together when diversity is considered from the beginning. Sponsors can broaden their reach through community-based sites, wider geographic coverage, culturally appropriate pre-screening, and structured referral workflows. Waiting until recruitment slows to address representation can create unnecessary delays. Early planning helps create a steadier enrollment pipeline while reaching populations that traditional site networks may miss. DecenTrialz supports AI-assisted participant matching, nurse-led pre-screening, and structured referral workflows for U.S.-based clinical studies.

Clinical trials depend on much more than a well-designed protocol. Behind every successful study is a carefully managed supply chain that ensures investigational products are stored, handled and delivered under the right conditions.

Clinical Storage and Distribution plays a critical role in maintaining the quality, availability and traceability of trial materials throughout the study lifecycle.

From receiving and storing clinical supplies to managing inventory and coordinating distribution to different trial locations, every stage requires careful planning. Factors such as temperature requirements, product handling, inventory visibility and delivery timelines can directly affect the continuity of a clinical study.

A reliable clinical storage and distribution strategy can help organizations:

• Maintain appropriate storage conditions for clinical trial materials • Improve inventory visibility and supply coordination • Support timely distribution to clinical trial sites • Reduce the risk of supply interruptions • Maintain better traceability throughout the supply chain

As clinical trials become increasingly global and complex, effective coordination between storage facilities, logistics partners and study teams becomes essential.

At Quantime World, we support clinical research organizations and pharmaceutical companies with clinical trial supply solutions, including drug storage and distribution, clinical trial supply logistics, comparator drug procurement and other specialized services.

A clinical trial referral does not move directly from interest to randomization. It passes through several stages, creating an eligibility funnel. The process usually starts with an external referral, followed by site pre-screening, a screening visit, informed consent, eligibility confirmation, and finally randomization. Each stage can influence how many candidates continue.

Tracking only referral numbers can hide where candidates are being lost. Stage-level tracking helps research teams understand whether challenges are related to referral quality, missing information, screening requirements, or operational delays. DecenTrialz supports the earlier part of this workflow through structured study matching and nurse-led pre-screening, while research sites retain responsibility for formal screening and eligibility decisions.

Artificial intelligence is becoming an increasingly important part of pharmaceutical research, and QuantHealth is focusing on one of the industry's biggest challenges: clinical trials.

The AI-powered clinical trial simulation company has raised $45 million in Series B funding, giving it additional resources to develop its technology and expand its work with pharmaceutical and biotechnology companies.

Using AI Before a Clinical Trial Begins

Clinical trials can require significant amounts of time, money, and resources. When a study fails, companies may lose years of development work along with substantial investments.

QuantHealth is taking a predictive approach.

Its platform allows researchers to simulate different clinical trial scenarios before enrolling patients. By testing potential study designs virtually, pharmaceutical teams can gain additional insights before moving into expensive real-world trials.

Creating Digital Patient Populations

One of the key components of the platform is AI-powered digital patient simulation.

The system can use clinical and biological information along with real-world healthcare data to model different patient populations and potential treatment responses.

Researchers can explore different combinations of patient criteria, dosage strategies, trial protocols, and endpoints.

This gives development teams an opportunity to identify potential problems and refine their strategies at an earlier stage.

Why This Could Matter for Drug Development

The pharmaceutical industry has increasingly adopted AI across drug discovery and research. Clinical trial optimization is another area where predictive technology could have a major impact.

By simulating possible outcomes earlier, companies may be able to improve trial planning, optimize recruitment approaches, and better understand potential risks.

The goal is not simply to make trials faster, but to make important development decisions more informed and data-driven.

QuantHealth's Next Growth Phase

The new $45 million investment is expected to support QuantHealth's technology development, scientific and engineering expansion, and commercial growth.

The company also plans to continue developing its digital twin technology and strengthen relationships with pharmaceutical and biotechnology organizations.

As AI continues to influence healthcare, platforms capable of simulating complex clinical scenarios could become an important part of future drug development strategies.

Commercial CAR-T vs clinical trials in China may look like a simple choice, but approval status, eligibility, timing, costs and international-patient access can differ significantly.

Our new evidence-informed guide explains:

• how an NMPA-approved commercial CAR-T pathway differs from investigational trial access; • why a trial marked “Recruiting” does not guarantee an available place; • what to clarify about screening, costs, apheresis, manufacturing and follow-up; and • what international patients should verify before committing to travel.

MedBridgeNZ helps international patients prepare and translate medical records, coordinate institutional enquiries and manage cross-border logistics in China. We are a New Zealand-based medical concierge provider and do not provide diagnosis, treatment, medical advice or trial-enrolment decisions.

Read the full guide: Commercial CAR-T vs Clinical Trials in China: What International Patients Need to Know